Unusual neonatal presentation of incontinentia pigmenti with persistent pulmonary hypertension of the newborn: A case report

Journal of Perinatology

Volumn 25, Issue 4, 2005, Pages 289-292

  Godambe, Sunit ^a   McNamara, Patrick ^a   Rajguru, Manju ^a   Hellmann, Jonathan ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN; INOTROPIC AGENT; MILRINONE; NITRIC OXIDE; PROSTAGLANDIN;

ARTICLE; CANDIDIASIS; CARDIOVASCULAR DISEASE; CASE REPORT; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL FEATURE; DISEASE ASSOCIATION; ENDOTRACHEAL INTUBATION; EYE DISEASE; FEMALE; HAIR DISEASE; HUMAN; HYPOTENSION; HYPOXEMIA; INCONTINENTIA PIGMENTI; INFANT; MUSCULOSKELETAL DISEASE; NEWBORN INTENSIVE CARE; POSITIVE END EXPIRATORY PRESSURE; PULMONARY HYPERTENSION; SKIN MANIFESTATION; TOOTH DISEASE;

FATAL OUTCOME; FEMALE; HUMANS; INCONTINENTIA PIGMENTI; INFANT, NEWBORN; NF-KAPPA B; PERSISTENT FETAL CIRCULATION SYNDROME;

EID: 17144384401     PISSN: 07438346     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jp.7211250     Document Type: Article

References (25)

1. Garrod AE. Peculiar pigmentation of the skin of the infant. Trans Clin Soc London 1906;39:216.
2. Shah SN, Gibbs S, Upton CJ, Pickworth FE, Garioch JJ. Incontinentia pigmenti associated with cerebral palsy and cerebral leukomalacia: a case report and literature review. Pediatr Dermatol 2003;20:491-4.
3. Bloch B. Eightumliche bisher nicht besmhriebene pigmentaffektion (incontenentia pigmenti). Schweiz Med Wehnschi 1926;7:404-5.
4. Kasman-Kellner B, Jurin-Bunte B, Ruprecht KW. Incontinentia pigmenti (Bloch-Sulzberger-syndrome): case report and differential diagnosis to related dermato-ocular syndromes. Ophthalmologica 1999;213:63-9.
5. Wood AE, Boyle D, O'Hara MD, Cleand J. Mitral annuloplasty in endomyocardial fibrosis: alternative to valve replacement. Ann Thorac Surg 1982;34:446-51.
6. Vachvanichsanong P, Jinorose U, Sangnuachua P. Trisomy 14 mosaicism in a 5-year-old boy. Am J Med Genet 1991;40:80-3.
7. Miteva L, Nikolova A. Incontinentia pigmenti: a case associated with cardiovascular anomalies. Pediatr Dermatol 2001;18:54-6.
8. Triki C, Devictor D, Kah S, et al. Cerebral complications of incontinentia pigmenti. A clinicopathological study of a case. Rev Neurol (Paris) 1992;148:773-6.
9. Smahi A, Courtois G, Vabres P, et al. Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The international Incontinentia Pigmenti (IP) Consortium. Nature 2000;405: 466-72.
10. Goldberg MF, Custis PH. Retinal and other manifestations of Incontinentia pigmenti (Bloch-Sulzberger syndrome). Ophthalmology 1993;100: 1645-1654.
11. Wiklund DA, Weston WL. Incontinentia pigmenti: a four-generation study. Arch Dermatol 1980;116:701-3.
12. Carney RG. Incontinentia pigmenti. A world statistical analysis. Arch Dermatol 1976;112:535-42.
13. Harre J, Millikan LE. Linear and whorled pigmentation. Int J Dermatol 1994;33:529-37.
14. Moss C, Ince P. Anhidrotic and achromians lesions in incontinentia pigmenti. Br J Dermatol 1987;116:839-49.
15. Worret WI, Nordquist RE, Burgdorf WH. Abnormal cutaneous nerves in incontinentia pigmenti. Ultrastruct Pathol 1988;12:449-54.
16. Rott HD. Partial sweat gland aplasia in incontinentia pigmenti Bloch-Sulzberger. Implications for nosologic classification. Clin Genet 1984;26:36-8.
17. Sefiani A, Abel L, Heuertz S, et al. The gene for incontinentia pigmenti is assigned to Xq28. Genomics 1989;4:427-9.
18. Smahi A, Hyden-Granskog C, Peterlin B, et al. The gene for the familial form of incontinentia pigmenti (IP2) maps to the distal part of Xq28. Hum Mol Genet 1994;3:273-8.
19. Jin DY, Jeang KT. Isolation of full-length cDNA and chromosomal localization of human NF-kappaB modulator NEMO to Xq28. J Biomed Sci 1999;6:115-20.
20. Baldwin Jr AS. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 1996;14:649-83.
21. Verma IM, Stevenson JK, Schwarz EM, Van Antwerp D, Miyamoto S. Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation. Genes Dev 1995;9:2723-35.
22. Makris C, Godfrey VL, Krahn-Senftleben G, et al. Female mice heterozygous for IKK gamma/NEMO deficiencies develop a dermatopathy similar to the human X-linked disorder incontinentia pigmenti. Mol Cell 2000;5:969-79.
23. Raychaudhuri B, Dweik R, Connors MJ, et al. Nitric oxide blocks nuclear factor-kappaB activation in alveolar macrophages. Am J Respir Cell Mol Biol 1999;21:311-6.
24. Ortiz LA, Champion HC, Lasky JA, et al. Enalapril protects mice from pulmonary hypertension by inhibiting TNF-mediated activation of NF-kappaB and AP-1. Am J Physiol Lung Cell Mol Physiol 2002;282:L1209-21.
25. Hennel SJ, Ekert PG, Volpe JJ, Inder TE. Insights into the pathogenesis of cerebral lesions in incontinentia pigmenti. Pediatr Neurol 2003;29:148-50.